Stockscreener 앱 받기
9.71
2.02%
-0.20
시간 외 거래:
9.64
-0.07
-0.72%
전일 마감가:
$9.91
열려 있는:
$10.13
하루 거래량:
1.41M
Relative Volume:
1.15
시가총액:
$632.47M
수익:
$170.16M
순이익/손실:
$-312.76M
주가수익비율:
-1.7084
EPS:
-5.6837
순현금흐름:
$-178.72M
1주 성능:
+23.69%
1개월 성능:
+40.72%
6개월 성능:
-16.22%
1년 성능:
+40.32%
1일 변동 폭
$9.51
$10.21
1주일 범위
$7.17
$10.60
52주 변동 폭
$5.37
$17.58
깅코 바이오웍스 홀딩스 Stock (DNA) Company Profile
명칭
Ginkgo Bioworks Holdings Inc
전화
(877) 442-5362
주소
27 DRYDOCK AVENUE, BOSTON
Compare DNA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
9.71 | 645.49M | 170.16M | -312.76M | -178.72M | -5.6837 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
깅코 바이오웍스 홀딩스 Stock (DNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-15 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-05-10 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-02 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-05-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 개시 | Berenberg | Buy |
| 2022-10-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2022-02-23 | 개시 | Goldman | Neutral |
| 2022-02-01 | 개시 | BofA Securities | Neutral |
| 2022-01-28 | 개시 | BofA Securities | Buy |
| 2022-01-07 | 개시 | BTIG Research | Buy |
| 2021-11-29 | 개시 | Jefferies | Buy |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-10-12 | 개시 | William Blair | Outperform |
| 2021-09-20 | 개시 | HSBC Securities | Buy |
모두보기
깅코 바이오웍스 홀딩스 주식(DNA)의 최신 뉴스
ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN
MSN Money - MSN
DNA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation - 富途牛牛
DNA Stock Price, Quote & Chart | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 11.1%What's Next? - MarketBeat
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - Quantisnow
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Will Ginkgo Bioworks Holdings (NYSE:DNA) Spend Its Cash Wisely? - Sahm
[ARS] Ginkgo Bioworks Holdings, Inc. SEC Filing - Stock Titan
Ginkgo Bioworks (NYSE: DNA) sets 2026 virtual meeting, auditor and pay votes - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) stock drops despite market gains: Important facts to note - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) increases despite market slip: Here's what you need to know - MSN
Price-Driven Insight from (DNA) for Rule-Based Strategy - Stock Traders Daily
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc. (DNA) and Encourages Investors with Significant Losses to Contact the Firm - TMX Newsfile
DNA Technical Analysis | Trend, Signals & Chart Patterns | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks Divests Biosecurity Unit, Refocuses Core Operations - TipRanks
Ginkgo Bioworks (NYSE:DNA) Trading 6.9% HigherHere's What Happened - MarketBeat
Ginkgo Bioworks CFO Steven Coen sells $2,576 in shares By Investing.com - Investing.com India
Ginkgo Bioworks CFO Steven Coen sells $2,576 in shares - Investing.com
Ginkgo Bioworks (NYSE: DNA) officer sells shares to cover taxes after RSU vesting - Stock Titan
DNA (NYSE: DNA) Form 144: Proposed sale of 324 Class A shares, insider sales listed - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Sector with a Potential 9% Upside - DirectorsTalk Interviews
(DNA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
DNA (NYSE: DNA) Rule 144 shows insider resale notices totaling tens of thousands of shares - Stock Titan
Short Interest in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Decreases By 23.2% - MarketBeat
Is Ginkgo Bioworks Holdings (NYSE:DNA) In A Good Position To Deliver On Growth Plans? - Moomoo
Steven Coen Sells 33,171 Shares of Ginkgo Bioworks (NYSE:DNA) Stock - MarketBeat
Ginkgo Bioworks CFO Coen sells $212k in shares By Investing.com - Investing.com South Africa
Ginkgo Bioworks CFO Coen sells $212k in shares - Investing.com
Ginkgo Bioworks (NYSE: DNA) CFO nets PSU shares, sells stock for taxes - Stock Titan
Ginkgo Bioworks (DNA) major shareholder sells $802k in stock By Investing.com - Investing.com South Africa
Ginkgo Bioworks (DNA) major shareholder sells $802k in stock - Investing.com
Ginkgo Bioworks (NYSE:DNA) Major Shareholder Barry Canton Sells 124,727 Shares - MarketBeat
PSU vesting drives tax share sale for Ginkgo Bioworks (DNA) holder - Stock Titan
Reshma Shetty of Ginkgo Bioworks (DNA) sells shares to cover tax after PSU vesting - Stock Titan
DNA (NYSE: DNA) files Form 144: 33,171 Class A shares tied to vesting - Stock Titan
Proposed Class A sale by DNA (NYSE: DNA) — Form 144 lists 40,893 shares - Stock Titan
Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Pr - GuruFocus
깅코 바이오웍스 홀딩스 (DNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):